Bellevue Life Sciences Acquisition Corp. (BLAC)
NASDAQ · Financial Services
Bellevue Life Sciences Acquisition Corp. EBITDA 2021–2023
Bellevue Life Sciences Acquisition Corp. annual/quarterly ebitda history and growth rate from 2021 to 2024. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Bellevue Life Sciences Acquisition Corp. ebitda for the quarter ending September 30, 2024 was -454132, a 10.65% increase year-over-year.
- Bellevue Life Sciences Acquisition Corp. ebitda for the twelve months ending September 30, 2024 was -2.2 M.
- Bellevue Life Sciences Acquisition Corp. annual ebitda for 2023 was -1.8 M, a 5073.22% increase from 2022.
- Bellevue Life Sciences Acquisition Corp. annual ebitda for 2022 was -35388, a 969.77% increase from 2021.
- Bellevue Life Sciences Acquisition Corp. annual ebitda for 2021 was -3308.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bellevue Life Sciences Acquisition Corp. EBITDA — FAQ
Bellevue Life Sciences Acquisition Corp. (BLAC) ebitda over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BLAC's ebitda history?
The chart and table above show Bellevue Life Sciences Acquisition Corp.'s ebitda by year and by quarter, including the growth rate.